September 26, 2018
Time: 4:00 PM - 5:00 PM
It's time again to hear from one of our resident companies and learn what's going on inside the Angiex lab. Their team will talk about their technology platform, vascular-targeted biotherapeutics.
Angiex targets fundamental aspects of endothelial biology with a focus on angiogenesis; its lead product is an antibody-drug conjugate therapy for cancer which aims to provide a rapid screen for CTCs with the highest metastatic potential, identify target organs for metastases, and enable discovery of small molecule inhibitors of the metastatic cascade.
Get an insight into their technology, ask questions. As always we have a 'Ch' food and this time it is chicken fried rice!